Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

Ryan K. Stansfield is a seasoned leader with over 23 years of experience in small molecule drug discovery and development. Currently serving as Director of DMPK-Toxicology at 858 Therapeutics, he has successfully led teams through critical phases of drug development, including managing IND-enabling toxicology studies and building high-performing scientific teams. Stansfield is recognized for his deep expertise in ADME, safety pharmacology, and toxicology, as well as his strategic ability to drive projects from discovery to clinical trials. Throughout his career, he has demonstrated exceptional communication skills, collaborating across functions and ensuring timely, rigorous data to support regulatory submissions. With a proven track record in managing budgets, experimental design, and in-licensing diligence, Stansfield has contributed to the successful advancement of multiple therapeutic candidates.

Dr. Chandra Shekhar Mishra is a distinguished scientist and technology strategist with over 35 years of expertise in high-energy physics, AI-driven research, and accelerator technology. Renowned for his leadership in large-scale scientific projects, he has played a pivotal role in advancing AI applications for data science, fostering international collaborations, and securing multi-million-dollar research initiatives. As a key architect of the US-India strategic partnership in accelerator technology, he successfully facilitated a $200 million agreement between the U.S. Department of Energy and India’s Department of Atomic Energy. With over 300 scientific publications and extensive experience in governance, strategic planning, and global negotiations, Dr. Mishra continues to drive innovation at the intersection of AI, energy, and high-tech industries. Now seeking board and advisory roles, he aims to leverage his expertise to help organizations accelerate technological breakthroughs, build strategic partnerships, and navigate complex industry challenges.